CU 62. Fascia dilator and transurethral scar resection with plasmakinetic for treatment of male urethrostenosis or urethratresia

Objective: To discuss the efficiency of fascia dilator and transurethral scar resection with plasmakinetic for treatment of male urethrostenosis or urethratresia.

Methods: 33 male patients with urethrostenosis or urethratresia are treated by fascia dilator and transurethral scar resection with plasmakinetic. The length of urethrostenosis or urethratresia are from 0.3 cm to 1.5 cm [mean (0.8±0.1) cm]. 4 patients with phallosome urethrostenosis and 1 patient with phallosome urethratresia, 15 patients with bulbourethra urethrostenosis and 4 patient with bulbourethra urethratresia, 9 patients with prostatic urethra urethrostenosis.

Results: The operation was successfully performed in all the 33 cases, with no urinary incontinence and much loss of blood. F18-F22 silica-gel catheters are reserved. The operative time was from 20 to 68 min [mean (36±4.7) min] and silica-gel catheters are keeped for 4-6 weeks. The maximum flow rate of urinary was 14.8- 32.4 mL/s [mean (21.3±2.6) mL/s] after1 week of removing the catheter. All the patients were followed up for 3-8 months. Only one patient received the same operation again and one patient received 4 times urethral dilatation, the other 31 patients were cured.

Conclusions: Fascia dilator and transurethral scar resection with plasmakinetic is a safe and effective method for the treatment of male urethrostenosis or urethratresia and it should be widely used.